Inovio Pharmaceuticals

Inovio Pharmaceuticals

Biotechnology
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

$115.9M

Market Cap • 9/17/2025

1983

(42 years)

Founded

1998

(27 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country